Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: in vitro and in vivo evaluation.

scientific article published on 18 March 2014

Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: in vitro and in vivo evaluation. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BIOPHA.2014.03.004
P698PubMed publication ID24721327

P50authorSanket M. ShahQ41497137
P2093author name stringRajiv P Gude
Ankitkumar S Jain
Mangal S Nagarsenker
Vivek V Dhawan
Peeyush N Goel
Yuvraj Nikam
P433issue4
P921main subjecttamoxifenQ412178
estrogen-receptor positive breast cancerQ18553636
P304page(s)429-438
P577publication date2014-03-18
P1433published inBiomedicine and PharmacotherapyQ15759648
P1476titleTamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: in vitro and in vivo evaluation
P478volume68

Reverse relations

cites work (P2860)
Q38708186Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development
Q51038520Electrosprayed Myocet-like Liposomes: An Alternative to Traditional Liposome Production.
Q38597794Lipid-based nanocarriers for breast cancer treatment - comprehensive review
Q38250517Nanoparticulate carriers: an emerging tool for breast cancer therapy
Q90163298Novel Tamoxifen Nanoformulations for Improving Breast Cancer Treatment: Old Wine in New Bottles
Q50058387Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Q26797230Use of Targeted Liposome-based Chemotherapeutics to Treat Breast Cancer

Search more.